Beta Bionics, Inc. BBNX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -71.39% | -38.73% | 23.59% | 25.64% | -45.94% |
| Total Depreciation and Amortization | 91.36% | 71.21% | 63.41% | 76.75% | 11.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 45.00% | 73.50% | -63.64% | -15.12% | 269.33% |
| Change in Net Operating Assets | 1,244.79% | 134.22% | -26.92% | 53.48% | 118.59% |
| Cash from Operations | -40.76% | -7.56% | -19.31% | 39.58% | 9.20% |
| Capital Expenditure | -77.46% | 41.60% | -313.51% | -239.22% | 33.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,138.31% | 251.76% | 112.99% | 108.80% | -37.26% |
| Cash from Investing | -1,302.61% | 336.30% | 112.19% | 102.22% | -37.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,066.60% | 4,188.10% | -99.70% | 2,689.47% | 5,667.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,066.60% | 4,188.10% | -99.70% | -98.14% | 325.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 991.88% | 291.25% | -111.40% | -153.35% | -23.42% |